IEEE Spectrum on MSN
At-home brain stimulation for depression is just the start
Flow’s headset is the first tDCS device approved by the FDA ...
A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...
A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study. A device that delivers direct stimulation to ...
The U.S. Food and Drug Administration cleared Flow Neuroscience’s at-home electrical stimulation headset for adults with moderate-to-severe depression A trial of 174 people found the device led to ...
The at-home brain stimulation device is expected to be available in the second quarter of 2026. The Food and Drug Administration (FDA) has cleared Flow, a prescription home-based cranial ...
Adding transcranial direct current stimulation (tDCS) to constraint-induced movement therapy (CIMT) after stroke offered no additional benefit in improving upper extremity function, new research ...
A new study suggests that a promising noninvasive brain stimulation technique may not function exactly as psychiatrists had ...
HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office ...
The transcranial direct current stimulation (tDCS) technique involves placing electrodes on the patient's skull. The prefrontal montage used in this study (left) represents the electric field ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results